Clinical trial
Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine (2018 Southern Hemisphere Season) Produced at Butantan Institute
NCT03392207 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine (2018 Southern Hemisphere Season) Produced at Butantan Institute
- Lead sponsor
- Butantan Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 23, 2018
- Completion date
- September 14, 2018
- Enrollment
- 403 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
influenza, human, orthomyxoviridae infections, physiological effects of drugs, respiratory tract infections, rna virus infections, vaccines, virus diseases